EH
IBB icon

Equitable Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Equitable Holdings’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6M Sell
31,528
-1,479
-4% -$254K 0.04% 402
2026
Q1 		$5.57M Buy
33,007
+9,715
+42% +$1.66M 0.04% 403
2025
Q4 		$3.93M Buy
23,292
+7,805
+50% +$1.27M 0.03% 434
2025
Q3 		$2.24M Sell
15,487
-501
-3% -$68.4K 0.02% 575
2025
Q2 		$2.02M Sell
15,988
-872
-5% -$107K 0.02% 569
2025
Q1 		$2.16M Buy
16,860
+127
+0.8% +$17.2K 0.02% 497
2024
Q4 		$2.21M Buy
16,733
+4,004
+31% +$563K 0.02% 465
2024
Q3 		$1.85M Sell
12,729
-1,018
-7% -$147K 0.02% 512
2024
Q2 		$1.89M Buy
13,747
+3,834
+39% +$512K 0.02% 480
2024
Q1 		$1.36M Sell
9,913
-364
-4% -$49.7K 0.02% 546
2023
Q4 		$1.4M Sell
10,277
-233
-2% -$28.4K 0.02% 504
2023
Q3 		$1.29M Sell
10,510
-89
-0.8% -$11.3K 0.02% 475
2023
Q2 		$1.35M Sell
10,599
-104
-1% -$13.5K 0.02% 443
2023
Q1 		$1.38M Buy
10,703
+378
+4% +$49.5K 0.02% 410
2022
Q4 		$1.36M Buy
10,325
+1,465
+17% +$189K 0.02% 374
2022
Q3 		$1.04M Buy
8,860
+346
+4% +$43K 0.02% 399
2022
Q2 		$1M Sell
8,514
-45
-0.5% -$5.34K 0.02% 408
2022
Q1 		$1.11M Sell
8,559
-4,601
-35% -$599K 0.02% 388
2021
Q4 		$2.01M Buy
13,160
+2,602
+25% +$403K 0.03% 280
2021
Q3 		$1.71M Buy
10,558
+193
+2% +$32.5K 0.03% 288
2021
Q2 		$1.7M Sell
10,365
-738
-7% -$114K 0.03% 277
2021
Q1 		$1.67M Sell
11,103
-2,700
-20% -$429K 0.04% 271
2020
Q4 		$2.09M Sell
13,803
-269
-2% -$38.4K 0.05% 216
2020
Q3 		$1.91M Buy
14,072
+241
+2% +$32.7K 0.05% 217
2020
Q2 		$1.89M Buy
13,831
+1,364
+11% +$174K 0.05% 213
2020
Q1 		$1.34M Sell
12,467
-3,200
-20% -$368K 0.05% 221
2019
Q4 		$1.89M Buy
+15,667
New +$1.75M 0.06% 203

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Equitable Holdings's IBB Position: Q2 2026 in Review

Equitable Holdings reduced its iShares Biotechnology ETF (IBB) stake by 4.5% in Q2 2026, selling an estimated $254K and leaving 31,528 shares worth $6M. The position accounts for 0.04% of the portfolio, ranked #402.

Equitable Holdings first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Equitable Holdings held 31,528 shares of iShares Biotechnology ETF worth $6M as of Q2 2026.
  • Equitable Holdings sold 1,479 iShares Biotechnology ETF shares in Q2 2026, an estimated $254K.
  • iShares Biotechnology ETF made up 0.04% of Equitable Holdings's portfolio in Q2 2026, its #402 holding.
  • Equitable Holdings first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.